25 February 2014
Using analytical technology developed to detect launched missiles, Lockheed Martin (NYSE: LMT) said it has discovered a way to identify sepsis, a potentially fatal blood condition, between 14 to 16 hours earlier than physicians currently do.
“Vitals and lab data are, essentially, continuously updated streams of information just like missile signals detected by our defense systems,” explained Melanie Lang, Lockheed Martin business development lead within Information Systems & Global Solutions. “Lockheed Martin took insights from real-time, streaming sensor data, detecting missiles at mach speeds, and reapplied those same techniques to real-time patient data.”
The company´s analytic framework, called Sia, monitors changing signals from the body and provides alerts for anomaly detection. In addition to the health field, Sia can be applied to other disciplines in which continuously changing signals need to be processed quickly and accurately.
In an initial trial, 4,500 patients were tested for sepsis using Lockheed Martin´s solution. It correctly alerted sepsis detection 90 percent of the time, while incorrectly labeling less than one percent of patients as potentially septic. The company said this is a significant improvement from the systemic inflammatory response syndrome method for detecting sepsis.
Headquartered in Bethesda, Md., Lockheed Martin is a global security and aerospace company that employs approximately 115,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services.
Lockheed Martin adapts missile defense analytics to early sepsis detection
25 February 2014